(MedPage Today) — Two late additions to BMJ’s annual Christmas series of offbeat research articles offered novel perspectives on physicians’ parking lot behaviors and the mysteries of “phantom vibration.”
No Comments »
Filed under: General Health News
(MedPage Today) — As part of the Year in Review series, MedPage Today reporters are revisiting major news stories and following up with an analysis of the impact of the original report, as well as subsequent news generated by the initial publication. Here’s what’s happened on the dietary supplement front since our Nov. 17, 2010, [...]
No Comments »
Filed under: Pharmacy News
(MedPage Today) — Our Year in Review series highlights the major medical news stories of 2010. The risks associated with dietary supplements was one of the compelling topics that made headlines during the year and here, again, is the original article, first published on Nov. 17, 2010. In a companion article, you’ll find out what’s [...]
No Comments »
Filed under: Pharmacy News
(MedPage Today) — Six lots of injectable acetylcysteine (Acetadote) manufactured by Cumberland Pharmaceuticals have been recalled because of particulate matter found in some vials, the company said.
No Comments »
Filed under: Pharmacy News
Ductal carcinoma in situ (DCIS), or non-invasive breast cancer, is typically treated with either breast-conserving surgery - with or without follow-up radiation - or mastectomy. The treatment choice depends on clinical factors, the treating surgeon, and patient preferences. Long-term health outcomes (disease-free survival) depend on the treatments received…
No Comments »
Filed under: Women's Health
Women are more likely to report use of indoor tanning facilities than men, and some characteristics common to indoor tanners differ by sex, according to a report in the December issue of Archives of Dermatology, one of the JAMA/Archives journals. However, few tanners - male or female - mention avoiding tanning beds when asked about [...]
No Comments »
Filed under: Women's Health
Endo Pharmaceuticals (Nasdaq: ENDP) announced, yesterday, that the U.S. Food and Drug Administration (FDA) has approved FORTESTA Gel for the treatment of low testosterone, or ‘Low T,’ also known as hypogonadism…
No Comments »
Filed under: Men's Health
